BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2607954)

  • 21. Personal best time, not anthropometry or training volume, is associated with total race time in a triple iron triathlon.
    Knechtle B; Knechtle P; Rosemann T; Senn O
    J Strength Cond Res; 2011 Apr; 25(4):1142-50. PubMed ID: 20651605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A profile of injuries in athletes seeking treatment during a triathlon race series.
    Gosling CM; Forbes AB; McGivern J; Gabbe BJ
    Am J Sports Med; 2010 May; 38(5):1007-14. PubMed ID: 20436054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon.
    Rifai N; Douglas PS; O'Toole M; Rimm E; Ginsburg GS
    Am J Cardiol; 1999 Apr; 83(7):1085-9. PubMed ID: 10190525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overuse injuries in ultraendurance triathletes.
    O'Toole ML; Hiller WD; Smith RA; Sisk TD
    Am J Sports Med; 1989; 17(4):514-8. PubMed ID: 2789479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between recreational male Ironman triathletes and marathon runners.
    Gianoli D; Knechtle B; Knechtle P; Barandun U; Rüst CA; Rosemann T
    Percept Mot Skills; 2012 Aug; 115(1):283-99. PubMed ID: 23033763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical and physiological factors associated with success in the triathlon.
    Sleivert GG; Rowlands DS
    Sports Med; 1996 Jul; 22(1):8-18. PubMed ID: 8819237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in pacing variation with increasing race duration in ultra-triathlon races.
    Stjepanovic M; Knechtle B; Weiss K; Nikolaidis PT; Cuk I; Thuany M; Sousa CV
    Sci Rep; 2023 Mar; 13(1):3692. PubMed ID: 36878948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluid and electrolyte status in athletes receiving medical care at an ultradistance triathlon.
    O'Toole ML; Douglas PS; Laird RH; Hiller DB
    Clin J Sport Med; 1995; 5(2):116-22. PubMed ID: 7882112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of participation and performance in age-group finishers competing in and qualifying for Ironman Hawaii.
    Stiefel M; Rüst CA; Rosemann T; Knechtle B
    Int J Gen Med; 2013; 6():67-77. PubMed ID: 23459419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate Metabolism During Ironman Triathlon: Different Horses on the Same Courses.
    Maunder E; Kilding AE; Plews DJ
    Sports Med; 2018 Oct; 48(10):2219-2226. PubMed ID: 29777386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance Trends in Age Group Triathletes in the Olympic Distance Triathlon at the World Championships 2009-2014.
    Wonerow M; Rüst CA; Nikolaidis PT; Rosemann T; Knechtle B
    Chin J Physiol; 2017 Jun; 60(3):137-150. PubMed ID: 28628968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of anthropometry on race performance in extreme endurance triathletes: World Challenge Deca Iron Triathlon 2006.
    Knechtle B; Knechtle P; Andonie JL; Kohler G
    Br J Sports Med; 2007 Oct; 41(10):644-8; discussion 648. PubMed ID: 17556527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bradykinin beta 2 receptor (BDKRB2) and endothelial nitric oxide synthase 3 (NOS3) genes and endurance performance during Ironman Triathlons.
    Saunders CJ; Xenophontos SL; Cariolou MA; Anastassiades LC; Noakes TD; Collins M
    Hum Mol Genet; 2006 Mar; 15(6):979-87. PubMed ID: 16461337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age and sex differences pertaining to modes of locomotion in triathlon.
    Stevenson JL; Song H; Cooper JA
    Med Sci Sports Exerc; 2013 May; 45(5):976-84. PubMed ID: 23247717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant within the AQP1 3'-untranslated region is associated with running performance, but not weight changes, during an Ironman Triathlon.
    Saunders CJ; Posthumus M; O'Connell K; September AV; Collins M
    J Sports Sci; 2015; 33(13):1342-8. PubMed ID: 25495276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ironman Triathlon].
    Knechtle B; Nikolaidis PT; Rosemann T; Rüst CA
    Praxis (Bern 1994); 2016 Jun; 105(13):761-73. PubMed ID: 27329709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AVPR2 gene and weight changes during triathlons.
    de Milander L; Kun MA; September AV; Schwellnus MP; Noakes TD; Collins M
    Int J Sports Med; 2012 Jan; 33(1):67-75. PubMed ID: 22052024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The medical perspective of the Kona Ironman Triathlon.
    Laird RH; Johnson D
    Sports Med Arthrosc Rev; 2012 Dec; 20(4):239. PubMed ID: 23147098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COL6A1 gene and Ironman triathlon performance.
    O'Connell K; Posthumus M; Collins M
    Int J Sports Med; 2011 Nov; 32(11):896-901. PubMed ID: 22012643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a multistage ultraendurance triathlon on aldosterone, vasopressin, extracellular water and urine electrolytes.
    Knechtle B; Morales NP; González ER; Gutierrez AA; Sevilla JN; Gómez RA; Robledo AR; Rodríguez AL; Fraire OS; Andonie JL; Lopez LC; Kohler G; Rosemann T
    Scott Med J; 2012 Feb; 57(1):26-32. PubMed ID: 22408212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.